The company has an annual yield of over 200 tons of cortical hormone active pharmaceutical ingredients, ranking first in global market share. Its stock has outperformed the market in turnover increase and investors are advised to pay close attention.

Source: Shanghai Securities News

Date: 4 Jul 2008

CN01/NW/MZ/BT/MM